SCHEMBL1430285

SCHEMBL1430285

CC(C)Oc1cc(CN2CCC3(CC2C)CN(C)S(=O)(=O)N3c2cccc(F)c2)ncc1O

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1170646 1.00 BACE1 (0.77) BACE1
SCHEMBL1170643 0.93 BACE1 (0.66) BACE1
SCHEMBL1170790 0.90 BACE1 (0.67) BACE1
SCHEMBL1170465 0.90 BACE1 (0.65) BACE1
SCHEMBL2555345 0.89 BACE1 (0.61) BACE1
SCHEMBL1170383 0.87 BACE1 (1.00) BACE1
SCHEMBL1430105 0.87 BACE1 (1.00) BACE1
SCHEMBL1171332 0.87 BACE1 (0.76) BACE1
SCHEMBL1170548 0.87 BACE1 (0.78) BACE1
SCHEMBL2555344 0.87 BACE1 (0.58) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO claimed
EP-2300484-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Pfizer Inc. (US) 2011-03-30 EP disclosed
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO disclosed